Related Experiment Video
Updated: Aug 8, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Sirolimus for Kaposi's sarcoma
Cara A Wasywich1, Margaret C Croxson, Gerard J van Doornum
1Green Lane Cardiovascular Service, Auckland District Health Board, Auckland, New Zealand. caraw@adhb.govt.nz
Abstract:
The risk of Kaposi's sarcoma (KS) is increased after organ transplantation. Management of KS in the cardiac transplant population may be difficult because reduction of immunosuppression is often not practical. This report describes a case of KS occurring in the early post-transplant period. Modification of immunosuppression with the use of sirolimus led to tumor regression for 24 months, but with subsequent localized progression of disease.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

